DrugPatentWatch Database Preview
KERYDIN Drug Profile
or, see our see our flat-rate plans
When do Kerydin patents expire, and what generic alternatives are available?
This drug has sixty-nine patent family members in twenty countries.
The generic ingredient in KERYDIN is tavaborole. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tavaborole profile page.
Summary for KERYDIN
| International Patents: | 69 |
| US Patents: | 5 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 56 |
| Patent Applications: | 55 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for KERYDIN |
| DailyMed Link: | KERYDIN at DailyMed |
Pharmacology for KERYDIN
| Ingredient-type | Boron Compounds |
| Drug Class | Oxaborole Antifungal |
| Mechanism of Action | Protein Synthesis Inhibitors |
Synonyms for KERYDIN
| 1,3-dihydro-5-fluoro-1-hydroxy-2,1-benzoxaborole |
| 174671-46-6 |
| 2,1-Benzoxaborole, 5-fluoro-1,3-dihydro-1-hydroxy- |
| 3338AH |
| 5-fluoro-1-hydroxy-3H-2,1-benzoxaborole |
| 5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole |
| 5-fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol |
| 5-fluoro-2,1-benzoxaborol-1(3H)-ol |
| 5-Fluoro-3H-benzo[c][1,2)oxaborol-1-ol |
| 5-fluoro-3H-benzo[c][1,2]oxaborol-1-ol |
| 5-FLUOROBENZO[C][1,2]OXABOROL-1(3H)-OL |
| AK163946 |
| AKOS006303927 |
| AN 2690 |
| AN-2690 |
| AN-2690(Tavaborole) |
| AN-2690) |
| AN2690 |
| BDBM50370987 |
| C7H6BFO2 |
| CHEBI:77942 |
| CHEMBL443052 |
| CS-1058 |
| CTK8H2675 |
| D05VGL |
| D10169 |
| DB09041 |
| DTXSID00169888 |
| EX-A1086 |
| FT-0697827 |
| Fungal leucyl-tRNA synthetase inhibitor (onychomycosis), Anacor Pharmaceuticals/Schering-Plough |
| Fungal leucyl-tRNA synthetase inhibitor (onychomycosis), Merck & Co/Anacor |
| HSDB 8342 |
| HY-10980 |
| K124A4EUQ3 |
| KB-74687 |
| Kerydin (TN) |
| KS-00000SPV |
| LFQDNHWZDQTITF-UHFFFAOYSA-N |
| MB08883 |
| MFCD10699483 |
| MolPort-027-845-281 |
| NCGC00264110-01 |
| SCH-900340 |
| SCHEMBL500016 |
| ST24044751 |
| Tavaborole |
| Tavaborole (USAN) |
| Tavaborole [USAN:INN] |
| Topical antifungal (onychomycosis), Merck & Co |
| Trichophyton-targeting antifungal (onychomycosis), Anacor Pharmaceuticals/Schering-Plough |
| Trichophyton-targeting antifungal (onychomycosis), Merck & Co |
| UNII-K124A4EUQ3 |
| W-5454 |
| X3699 |
| Z1739256284 |
| ZINC169990691 |
US Patents and Regulatory Information for KERYDIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anacor Pharms Inc | KERYDIN | tavaborole | SOLUTION;TOPICAL | 204427-001 | Jul 7, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Anacor Pharms Inc | KERYDIN | tavaborole | SOLUTION;TOPICAL | 204427-001 | Jul 7, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Anacor Pharms Inc | KERYDIN | tavaborole | SOLUTION;TOPICAL | 204427-001 | Jul 7, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Anacor Pharms Inc | KERYDIN | tavaborole | SOLUTION;TOPICAL | 204427-001 | Jul 7, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
Non-Orange Book US Patents for KERYDIN
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,440,642 | Boron-containing small molecules | ➤ Sign Up |
| 8,889,656 | Boron-containing small molecules | ➤ Sign Up |
| 9,353,133 | Boron-containing small molecules | ➤ Sign Up |
| 7,767,657 | Boron-containing small molecules | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
or, see our see our flat-rate plans
International Patents for KERYDIN
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2016199561 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2006089067 | ➤ Sign Up |
| Japan | 2014132031 | ➤ Sign Up |
| Russian Federation | 2414906 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
